AB0935 Canadian adalimumab post-marketing observational epidemiological study assessing the effectiveness of adalimumab vs non-biologic dmards in psoriatic arthritis (COMPLETE-PSA): 12-month effectiveness data

Background To date, observational studies comparing the effectiveness of adalimumab (ADA) to non-biologic DMARDs (nbDMARD) in psoriatic arthritis (PsA) patients failing prior treatment are scarce. COMPLETE-PSA is a Canadian post-marketing observational study which assessed real-life effectiveness of ADA and non-biological therapies (NSAIDs and DMARDs) in PsA management following initial treatment failure. Objectives This analysis aimed to …